Skip to main content

Advertisement

SpringerLink
Log in

Nitazoxanide in the Treatment of Intestinal Parasitic Infections in Children: A Systematic Review and Meta-Analysis

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the efficacy and safety of nitazoxanide in intestinal parasitic infections in children.

Methods

Four databases, PubMed, EMBASE, Web of Science and Cochrane Library, have been systematically searched from the inception of each database up to March 1st, 2019. The enrolled studies were limited to randomized clinical trials in children, comparing nitazoxanide with placebo or other antiparasitic drugs. The data extraction and quality assessment of pooled studies were conducted by two reviewers independently. For meta-analysis, Stata12.0 was used and a randomized effect model or a fixed effect model was selected according to the outcomes of heterogeneity test.

Results

A total of 1645 subjects in 13 randomized controlled trials (RCTs) were enrolled, including 768 cases in the trial group and 877 cases in the control group. The effect of nitazoxanide vs. placebo and other antiparasitic drugs on the excretion rate of pathogens was uncertain (OR = 2.06, 95%CI [1.01,4.20], P = 0.047; I2 = 84.7%; very low quality evidence). Compared with placebo, subgroup analysis suggested that nitazoxanide could significantly improve the excretion rate of pathogens (OR = 7.01, 95%CI [1.82,26.94], P = 0.005; I2 = 79.1%; moderate quality evidence), while it made little or no difference compared with antiparasitic drugs (OR = 0.72, 95%CI [0.47,1.09], P = 0.124; I2 = 33.1%; low quality evidence). Meanwhile, nitazoxanide might increase the remission rate of diarrhea with OR = 5.12, 95%CI [2.00,13.08], P = 0.001; I2 = 72.3%; low quality evidence). However, it might also increase the rate of adverse events (OR = 1.47, 95%CI [1.05,2.07], P = 0.026; I2 = 44.7%; low quality evidence).

Conclusions

The authors are uncertain whether or not nitazoxanide could improve the excretion rate of pathogens. Based on low-certainty evidence, nitazoxanide may improve the remission rate of diarrhea in children with intestinal parasite infections, but it may be associated with an increased risk of adverse reactions. Hence, more RCTs with a low risk of bias are still needed to assess the efficacy and safety of nitazoxanide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Goncalves AQ, Junqueira ACV, Abellana R, et al. Prevalence of intestinal parasites and risk factors for specific and multiple helminth infections in a remote city of the Brazilian Amazon. Rev Soc Bras Med Trop. 2016;49:119–24.

    Article  Google Scholar 

  2. Muller I, Yap P, Steinmann P, et al. Intestinal parasites, growth and physical fitness of schoolchildren in poor neighbourhoods of Port Elizabeth, South Africa: a cross-sectional survey. Parasit Vectors. 2016;9:488.

  3. Shobha M, Bithika D, Bhavesh S. The prevalence of intestinal parasitic infections in the urban slums of a city in Western India. J Infect Public Health. 2013;6:142–9.

    Article  Google Scholar 

  4. Kaur R, Rawat D, Kakkar M, Uppal B, Sharma VK. Intestinal parasites in children with diarrhea in Delhi, India. Southeast Asian J Trop Med Public Health. 2002;33:725–9.

  5. World Health Organization. Soil-Transmitted Helminth Infections. Available at: https://www.who.int/news-room/fact-sheets/detail/soil-transmitted-helminth-infections. Accessed 14th March 2019.

  6. Xu LQ. [A national survey on current status of the important parasitic diseases in human population]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005;23:332–40 (in Chinese).

  7. Hotez PJ, Fenwick A, Savioli L, Molyneux DH. Rescuing the bottom billion through control of neglected tropical diseases. Lancet. 2009;373:1570–5.

    Article  Google Scholar 

  8. Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, GEMS): a prospective, case-control study. Lancet. 2013;382:209–22.

    Article  Google Scholar 

  9. Sarkar R, Tate JE, Ajjampur SSR, et al. Burden of diarrhea, hospitalization and mortality due to cryptosporidial infections in Indian children. PLoS Negl Trop Dis. 2014;8:e3042.

    Article  Google Scholar 

  10. Stanley SJ. Amoebiasis. Lancet. 2003;361:1025–34.

    Article  CAS  Google Scholar 

  11. Ortiz-Castillo F, Salinas-Aragon LE, Sanchez-Aguilar M, et al. Amoebic toxic colitis: analysis of factors related to mortality. Pathog Glob Health. 2012;106:245–8.

    Article  Google Scholar 

  12. Squire SA, Ryan U. Cryptosporidium and Giardia in Africa: current and future challenges. Parasit Vectors. 2017;10:195.

    Article  Google Scholar 

  13. Borkow G, Bentwich Z. Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev. 2004;17:1012–30.

    Article  CAS  Google Scholar 

  14. Alemu A, Shiferaw Y, Getnet G, Yalew A, Addis Z. Opportunistic and other intestinal parasites among HIV/AIDS patients attending Gambi higher clinic in Bahir Dar city, north West Ethiopia. Asian Pac J Trop Med. 2011;4:661–5.

    Article  Google Scholar 

  15. Jha AK, Uppal B, Chadha S, et al. Clinical and microbiological profile of HIV/AIDS cases with diarrhea in north India. J Pathog. 2012;2012:971958.

    Article  Google Scholar 

  16. Murray CJ, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384:1005–70.

    Article  Google Scholar 

  17. Anderson VR, Curran MP. Nitazoxanide: a review of its use in the treatment of gastrointestinal infections. Drugs. 2007;67:1947–67.

    Article  CAS  Google Scholar 

  18. Abboud P, Lemée V, Gargala G, et al. Successful treatment of metronidazole-and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clin Infect Dis. 2001;32:1792–4.

    Article  CAS  Google Scholar 

  19. Rodriguez-Garcia R, Rodriguez-Guzman LM, Cruz DCA. Effectiveness and safety of mebendazole compared to nitazoxanide in the treatment of Giardia lamblia in children. Rev Gastroenterol Mex. 1999;64:122–6.

    CAS  PubMed  Google Scholar 

  20. Ortiz JJ, Ayoub A, Gargala G, Lopez-Chegne N, Favennec L. Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru. Aliment Pharmacol Ther. 2001;15:1409–15.

    Article  CAS  Google Scholar 

  21. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. 2001;184:103–6.

    Article  CAS  Google Scholar 

  22. Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 2002;360:1375–80.

    Article  Google Scholar 

  23. Davila-Gutierrez CE, Vasquez C, Trujillo-Hernandez B, Huerta M. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. Am J Trop Med Hyg. 2002;66:251–4.

    Article  CAS  Google Scholar 

  24. Ortiz JJ, Lopez-Chegne N, Gargala G, Favennec L. Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru. Trans R Soc Trop Med Hyg. 2002;96:193–6.

    Article  CAS  Google Scholar 

  25. Favennec L, Ortiz JJ, Gargala G, et al. Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Aliment Pharmacol Ther. 2003;17:265–70.

    Article  CAS  Google Scholar 

  26. Belkind-Valdovinos U, Belkind-Gerson J, Sanchez-Francia D, Espinoza-Ruiz MM, Lazcano-Ponce E. Nitazoxanide vs albendazole against intestinal parasites in a single dose and for three days. Salud Publica Mex. 2004;46:333–40.

    Article  Google Scholar 

  27. Rossignol JF, Kabil SM, Said M, Samir H, Younis AM. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol. 2005;3:987–91.

    Article  CAS  Google Scholar 

  28. Rossignol JF, Kabil SM, El-Gohary Y, Younis AM. Nitazoxanide in the treatment of amoebiasis. Trans R Soc Trop Med Hyg. 2007;101:1025–31.

    Article  CAS  Google Scholar 

  29. Escobedo AA, Alvarez G, Gonzalez ME, et al. The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide. Ann Trop Med Parasitol. 2008;102:199–207.

    Article  CAS  Google Scholar 

  30. Amadi B, Mwiya M, Sianongo S, et al. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis. 2009;9:195.

    Article  Google Scholar 

  31. Speich B, Ame SM, Ali SM, et al. Efficacy and safety of nitazoxanide, albendazole, and nitazoxanide-albendazole against Trichuris trichiura infection: a randomized controlled trial. PLoS Negl Trop Dis. 2012;6:e1685.

    Article  Google Scholar 

  32. Hussien SM, Abdella OH, Abu-Hashim AH, et al. Comparative study between the effect of nitazoxanide and paromomycine in treatment of cryptosporidiosis in hospitalized children. J Egypt Soc Parasitol. 2013;43:463–70.

    Article  Google Scholar 

  33. Cabello RR, Guerrero LR, Garcia MRM, Cruz AG. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans R Soc Trop Med Hyg. 1997;91:701–3.

    Article  CAS  Google Scholar 

  34. Gurgen J, Hogan D, Grace E, Johnson D. Nitazoxanide in the treatment of chronic cutaneous leishmaniasis resistant to traditional sodium stibogluconate. J Am Acad Dermatol. 2011;64:202–3.

    Article  Google Scholar 

  35. Abubakar I, Aliyu SH, Arumugam C, Usman NK, Hunter PR. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. Br J Clin Pharmacol. 2007;63:387–93.

    Article  CAS  Google Scholar 

  36. Doumbo O, Rossignol JF, Pichard E, et al. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa. Am J Trop Med Hyg. 1997;56:637–9.

    Article  CAS  Google Scholar 

  37. Rodriguez-Perez MA, Perez-Vega JA, Cen-Aguilar JF, Rodríguez-Canul R. Lessons from a study in a rural community from southern Mexico: risk factors associated to transmission and reinfection of gastrointestinal parasites after albendazole treatment. Res Rep Trop Med. 2011;2:147–53.

    PubMed  PubMed Central  Google Scholar 

  38. Rossignol JF, Lopez-Chegne N, Julcamoro LM, Carrion ME, Bardin MC. Nitazoxanide for the empiric treatment of pediatric infectious diarrhea. Trans R Soc Trop Med Hyg. 2012;106:167–73.

    Article  CAS  Google Scholar 

  39. Waddington CS, McLeod C, Morris P, et al. The NICE-GUT trial protocol: a randomised, placebo-controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian aboriginal children. BMJ Open. 2018;8:e019632.

    Article  Google Scholar 

  40. Bojar H, Knap JP. Nitazoxanide ("Alinia")- a promising antiparasitic drug. Wiad Parazytol. 2010;56:11–8.

    PubMed  Google Scholar 

  41. Stockis A, De Bruyn S, Gengler C, Rosillon D. Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing with 0.5 g and 1 g b.i.d. Int J Clin Pharmacol Ther. 2002;40:221–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Children’s Hospital of Chongqing Medical University, Chongqing, 400014, China

    Jinyi Li & Xue Zhan

  2. Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Pediatrics, Chongqing, China

    Jinyi Li & Xue Zhan

  3. Department of Cardiology, Children’s Hospital of Chongqing Medical University, Chongqing, China

    Hongyu Kuang

Authors
  1. Jinyi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongyu Kuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xue Zhan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JL contributed to study design, literature search, systematic review and data collection, statistical analysis, interpretation of results, and preparation of the manuscript. HK contributed to literature search, systematic review, data collection, and corrected the grammatical errors. XZ is the adviser of the study and will act as guarantor for this paper.

Corresponding author

Correspondence to Xue Zhan.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Kuang, H. & Zhan, X. Nitazoxanide in the Treatment of Intestinal Parasitic Infections in Children: A Systematic Review and Meta-Analysis. Indian J Pediatr 87, 17–25 (2020). https://doi.org/10.1007/s12098-019-03098-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-019-03098-w

Keywords

Search

Navigation